Skip to content
CancerIndex

Ranking · Unmet Need

Trial Gap Index

Burden percentile minus active-trial percentile within the same scope. Positive values flag cancers with high mortality burden but comparatively few active trials. A quantitative signal, not an accusation (CLAUDE.md §324). Caveat (Phase 1): trial counts aggregate a cancer and its NCIt descendants only; registrations phrased at a broader level (e.g. "colorectal cancer" for colon and rectal cancer) are attributed to the broader entity, which can overstate the gap of narrower top-level sites.

Computedci-trial-gap-v1unit: percentile pointshigher = worseAll metrics

Top 15 by Trial Gap IndexMalignant Colon Neoplasm+56.7Cutaneous Melanoma+20Malignant Laryngeal Neoplasm+20Malignant Bladder Neoplasm+16.6Malignant Vulvar Neoplasm+10Malignant Ovarian Neoplasm+6.7Malignant Pancreatic Neoplasm+6.7Malignant Vaginal Neoplasm+6.7Malignant Esophageal Neoplasm+3.4Malignant Salivary Gland Neop…+3.3Malignant Testicular Neoplasm+3.3Malignant Mesothelioma+3.3Malignant Prostate Neoplasm+3.3Malignant Kidney Neoplasm0Malignant Lung Neoplasm0
RankΔCancerTrial Gap Index (percentile points)PercentileConfidenceSourcesWhy #n?
1=Malignant Colon Neoplasm+56.7100Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
47987
formula
percentile(mortality_count) − percentile(active_trials)
activity
225
burdenPercentile
96.7
activityPercentile
40

ranking row 2593354

2=Cutaneous Melanoma+2096.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
7513
formula
percentile(mortality_count) − percentile(active_trials)
activity
78
burdenPercentile
46.7
activityPercentile
26.7

ranking row 2593355

3=Malignant Laryngeal Neoplasm+2093.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
3722
formula
percentile(mortality_count) − percentile(active_trials)
activity
66
burdenPercentile
40
activityPercentile
20

ranking row 2593356

4=Malignant Bladder Neoplasm+16.690Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
12627
formula
percentile(mortality_count) − percentile(active_trials)
activity
346
burdenPercentile
63.3
activityPercentile
46.7

ranking row 2593357

5=Malignant Vulvar Neoplasm+1086.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
794
formula
percentile(mortality_count) − percentile(active_trials)
activity
54
burdenPercentile
23.3
activityPercentile
13.3

ranking row 2593358

6=Malignant Ovarian Neoplasm+6.783.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
14682
formula
percentile(mortality_count) − percentile(active_trials)
activity
684
burdenPercentile
76.7
activityPercentile
70

ranking row 2593360

6=Malignant Pancreatic Neoplasm+6.783.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
30263
formula
percentile(mortality_count) − percentile(active_trials)
activity
904
burdenPercentile
86.7
activityPercentile
80

ranking row 2593359

8=Malignant Vaginal Neoplasm+6.776.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
378
formula
percentile(mortality_count) − percentile(active_trials)
activity
31
burdenPercentile
6.7
activityPercentile
0

ranking row 2593361

9=Malignant Esophageal Neoplasm+3.473.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
12700
formula
percentile(mortality_count) − percentile(active_trials)
activity
518
burdenPercentile
66.7
activityPercentile
63.3

ranking row 2593362

10=Malignant Salivary Gland Neoplasm+3.370Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
722
formula
percentile(mortality_count) − percentile(active_trials)
activity
63
burdenPercentile
20
activityPercentile
16.7

ranking row 2593363

11=Malignant Testicular Neoplasm+3.366.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
393
formula
percentile(mortality_count) − percentile(active_trials)
activity
43
burdenPercentile
10
activityPercentile
6.7

ranking row 2593364

12=Malignant Mesothelioma+3.363.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
2430
formula
percentile(mortality_count) − percentile(active_trials)
activity
96
burdenPercentile
33.3
activityPercentile
30

ranking row 2593365

12=Malignant Prostate Neoplasm+3.363.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
30446
formula
percentile(mortality_count) − percentile(active_trials)
activity
1375
burdenPercentile
90
activityPercentile
86.7

ranking row 2593366

14=Malignant Kidney Neoplasm056.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
12165
formula
percentile(mortality_count) − percentile(active_trials)
activity
453
burdenPercentile
56.7
activityPercentile
56.7

ranking row 2593368

14=Malignant Lung Neoplasm056.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
157630
formula
percentile(mortality_count) − percentile(active_trials)
activity
2644
burdenPercentile
100
activityPercentile
100

ranking row 2593367

14=Malignant Rectal Neoplasm056.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
8616
formula
percentile(mortality_count) − percentile(active_trials)
activity
386
burdenPercentile
50
activityPercentile
50

ranking row 2593369

17=Malignant Thyroid Gland Neoplasm-3.346.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
1367
formula
percentile(mortality_count) − percentile(active_trials)
activity
176
burdenPercentile
30
activityPercentile
33.3

ranking row 2593370

18=Malignant Breast Neoplasm-3.443.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
41883
formula
percentile(mortality_count) − percentile(active_trials)
activity
2627
burdenPercentile
93.3
activityPercentile
96.7

ranking row 2593371

19=Malignant Hypopharyngeal Neoplasm-6.740Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
323
formula
percentile(mortality_count) − percentile(active_trials)
activity
53
burdenPercentile
3.3
activityPercentile
10

ranking row 2593372

19=Malignant Penile Neoplasm-6.740Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
209
formula
percentile(mortality_count) − percentile(active_trials)
activity
43
burdenPercentile
0
activityPercentile
6.7

ranking row 2593373

21=Malignant Central Nervous System Neoplasm-6.733.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
12830
formula
percentile(mortality_count) − percentile(active_trials)
activity
823
burdenPercentile
70
activityPercentile
76.7

ranking row 2593374

21=Malignant Gastric Neoplasm-6.733.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
12198
formula
percentile(mortality_count) − percentile(active_trials)
activity
652
burdenPercentile
60
activityPercentile
66.7

ranking row 2593375

23=Leukemia-1026.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
21581
formula
percentile(mortality_count) − percentile(active_trials)
activity
1769
burdenPercentile
80
activityPercentile
90

ranking row 2593376

23=Malignant Anal Neoplasm-1026.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
539
formula
percentile(mortality_count) − percentile(active_trials)
activity
68
burdenPercentile
13.3
activityPercentile
23.3

ranking row 2593379

23=Malignant Liver Neoplasm-1026.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
14047
formula
percentile(mortality_count) − percentile(active_trials)
activity
906
burdenPercentile
73.3
activityPercentile
83.3

ranking row 2593378

23=Non-Hodgkin Lymphoma-1026.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
21910
formula
percentile(mortality_count) − percentile(active_trials)
activity
2168
burdenPercentile
83.3
activityPercentile
93.3

ranking row 2593377

27=Hodgkin Lymphoma-1013.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
1352
formula
percentile(mortality_count) − percentile(active_trials)
activity
179
burdenPercentile
26.7
activityPercentile
36.7

ranking row 2593380

28=Malignant Uterine Corpus Neoplasm-16.610Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
3187
formula
percentile(mortality_count) − percentile(active_trials)
activity
411
burdenPercentile
36.7
activityPercentile
53.3

ranking row 2593381

29=Malignant Cervical Neoplasm-16.76.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
3952
formula
percentile(mortality_count) − percentile(active_trials)
activity
505
burdenPercentile
43.3
activityPercentile
60

ranking row 2593382

30=Multiple Myeloma-203.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
10913
formula
percentile(mortality_count) − percentile(active_trials)
activity
814
burdenPercentile
53.3
activityPercentile
73.3

ranking row 2593383

31=Malignant Nasopharyngeal Neoplasm-26.60Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
628
formula
percentile(mortality_count) − percentile(active_trials)
activity
261
burdenPercentile
16.7
activityPercentile
43.3

ranking row 2593384

Data updated 16 hours agoSource updated unknown31 eligible entities · inputs hash 863aaaf4a1aa803d9d01adc8